Detalhe da pesquisa
1.
PP2A-based triple-strike therapy overcomes mitochondrial apoptosis resistance in brain cancer cells.
Mol Oncol
; 17(9): 1803-1820, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37458534